| Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation R Sciammas, AL Shaffer, JH Schatz, H Zhao, LM Staudt, H Singh Immunity 25 (2), 225-236, 2006 | 667 | 2006 |
| RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer AL Wolfe, K Singh, Y Zhong, P Drewe, VK Rajasekhar, VR Sanghvi, ... Nature 513 (7516), 65-70, 2014 | 630 | 2014 |
| A targeted mutational landscape of angioimmunoblastic T-cell lymphoma O Odejide, O Weigert, AA Lane, D Toscano, MA Lunning, N Kopp, S Kim, ... Blood, The Journal of the American Society of Hematology 123 (9), 1293-1296, 2014 | 427 | 2014 |
| The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma E Oricchio, G Nanjangud, AL Wolfe, JH Schatz, KJ Mavrakis, M Jiang, ... Cell 147 (3), 554-564, 2011 | 220 | 2011 |
| Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma JH Schatz, E Oricchio, AL Wolfe, M Jiang, I Linkov, J Maragulia, W Shi, ... Journal of experimental medicine 208 (9), 1799-1807, 2011 | 140 | 2011 |
| Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1 L Li, P Pongtornpipat, T Tiutan, SL Kendrick, S Park, DO Persky, ... Leukemia 29 (8), 1702-1712, 2015 | 106 | 2015 |
| Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis JH Schatz, SM Horwitz, J Teruya-Feldstein, MA Lunning, A Viale, ... Leukemia 29 (1), 237-241, 2015 | 83 | 2015 |
| Statins enhance efficacy of venetoclax in blood cancers JS Lee, A Roberts, D Juarez, TTT Vo, S Bhatt, L Herzog, S Mallya, ... Science translational medicine 10 (445), eaaq1240, 2018 | 80 | 2018 |
| A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas AJ Moskowitz, P Ghione, E Jacobsen, J Ruan, JH Schatz, S Noor, ... Blood, The Journal of the American Society of Hematology 138 (26), 2828-2837, 2021 | 79 | 2021 |
| T cell–activating bispecific antibodies in cancer therapy A Trabolsi, A Arumov, JH Schatz The Journal of Immunology 203 (3), 585-592, 2019 | 76 | 2019 |
| Evidence suggesting that discontinuous dosing of ALK kinase inhibitors may prolong control of ALK+ tumors AD Amin, SS Rajan, WS Liang, P Pongtornpipat, MJ Groysman, EO Tapia, ... Cancer research 75 (14), 2916-2927, 2015 | 57 | 2015 |
| Targeting the PI3K/AKT/mTOR pathway in non-Hodgkin’s lymphoma: results, biology, and development strategies JH Schatz Current oncology reports 13, 398-406, 2011 | 52 | 2011 |
| Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma MD Jain, B Ziccheddu, CA Coughlin, R Faramand, AJ Griswold, KM Reid, ... Blood, The Journal of the American Society of Hematology 140 (5), 491-503, 2022 | 46 | 2022 |
| Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with In Vivo Antitumor Activity TL Peters, J Tillotson, AM Yeomans, S Wilmore, E Lemm, ... Clinical Cancer Research 24 (17), 4256-4270, 2018 | 45 | 2018 |
| Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy E Oricchio, G Ciriello, M Jiang, MH Boice, JH Schatz, A Heguy, A Viale, ... Journal of Experimental Medicine 211 (7), 1379-1391, 2014 | 41 | 2014 |
| A network of RNA-binding proteins controls translation efficiency to activate anaerobic metabolism JJD Ho, NC Balukoff, PR Theodoridis, M Wang, JR Krieger, JH Schatz, ... Nature communications 11 (1), 2677, 2020 | 40 | 2020 |
| Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis SH Jo, JH Schatz, J Acquaviva, H Singh, R Ren Blood, The Journal of the American Society of Hematology 116 (15), 2759-2767, 2010 | 40 | 2010 |
| Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer? AD Amin, TL Peters, L Li, SS Rajan, R Choudhari, SD Puvvada, ... Molecular Case Studies 3 (3), a001719, 2017 | 36 | 2017 |
| Complications of intrathecal chemotherapy in adults: single-institution experience in 109 consecutive patients DM Byrnes, F Vargas, C Dermarkarian, R Kahn, D Kwon, J Hurley, ... Journal of oncology 2019, 2019 | 35 | 2019 |
| ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4A J Tillotson, M Kedzior, L Guimarães, AB Ross, TL Peters, AJ Ambrose, ... Bioorganic & medicinal chemistry letters 27 (17), 4082-4085, 2017 | 34 | 2017 |
Hans-Guido WendelMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
